Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$1.27 USD
-0.01 (-0.78%)
Updated Sep 13, 2024 03:59 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) reported earnings of -$0.43 per share, missing the Zacks Consensus Estimate of -$0.42 per share. This reflects a negative earnings surprise of 2.38%. Look out for BRNS's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year decrease of 21.62%.
Earnings History
Price & Consensus
Zacks News for BRNS
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
BRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services